Safety Advisory: Unauthorized Injectable Peptide Drugs
The College of Registered Nurses of Saskatchewan (CRNS) is sharing information regarding a Health Canada safety advisory warning about the use of unauthorized injectable peptide drugs.
Unauthorized health products may pose serious health risks as they have not been approved by Health Canada for safety, efficacy or quality.
These products include retatrutide, currently being studied in Phase 3 clinical trials for obesity, type 2 diabetes and other related indications. Retatrutide has not been approved by Health Canada for human use. Eli Lilly Canada recently issued a public safety notice regarding unapproved retatrutide products being sold through unauthorized sources.
RNs and NPs should be aware that patients may report using, purchasing or seeking access to unapproved retatrutide products or other unauthorized injectable peptide drugs.
As with all medications and health products, RNs and NPs are expected to act within their individual scope of practice and applicable standards, and to use professional judgment when assessing, educating and caring for patients.
Learn more:
External Consultation: RNs Working in Special-Care Homes
The College of Registered Nurses of Saskatchewan (CRNS) is revising the RNs Working in Special-Care Homes resource. As part of the external consultation process, the CRNS is seeking feedback from registrants and external partners, including the public.
This review is being conducted through an online survey that will allow you to provide feedback on individual sections of the resource document. A draft copy of the updated resource is available to review while completing the survey.
- Review the updated draft RNs Working in Special-Care Homes
- Access the survey here
The deadline to provide feedback is September 17, 2026, at 4:00 pm. Your responses will be anonymous and confidential.
Questions or comments are welcome and can be directed to Carole Reece at creece@crns.ca.
External Consultation: Documentation Guideline and Social Media Resource
The College of Registered Nurses of Saskatchewan (CRNS) is revising its Documentation Guideline and Social Media Resource. As part of the external consultation process, CRNS is inviting feedback on both documents from registrants and external partners, including the public.
Feedback will be collected through separate online surveys for each document. An updated draft version of each document is available to review as you complete the corresponding survey, allowing you to provide feedback on individual sections.
Documentation Guideline
- Review the updated draft Documentation Guideline
- Access the survey here
- Questions or comments can be directed to Donna Marin at dmarin@crns.ca.
Social Media Resource
- Review the updated draft Social Media Resource
- Access the survey here
- Questions or comments can be directed to Virginia Deobald at vdeobald@crns.ca.
The deadline to provide feedback for both consultations is September 3, 2026, at 4:30 pm. Your responses will be anonymous and confidential.
Saskatchewan Biosimilars Initiative: End of Initiative Period for Actemra, Stelara, and Xolair
The end of the Saskatchewan Biosimilars Initiative transition period for Actemra, Stelara and Xolair is July 31, 2026.
Starting August 1, 2026, the following reference biologics are no longer eligible for coverage under the Saskatchewan Drug Plan:
- Actemra (tocilizumab)
- Stelara (ustekinumab)
- Xolair (omalizumab)
Under the Saskatchewan Biosimilars Initiative, patients receiving one of these reference biologics must transition to a biosimilar version to maintain Saskatchewan Drug Plan coverage of their treatment after July 31, 2026.
For more information, visit:
Consultation Survey for Proposed Bylaw Amendments
The College of Registered Nurses of Saskatchewan (CRNS) is currently seeking feedback on proposed amendments to the CRNS Bylaws.
Please review the proposed amendments here and complete the survey to participate in the consultation process. The deadline to provide feedback is Friday, August 14, 2026, at 4:30 pm.
Questions or written feedback can be directed to Donna Marin at dmarin@crns.ca.
External Consultation: Medication Management Guideline
The College of Registered Nurses of Saskatchewan (CRNS) is revising the Medication Management Guideline. As part of the external consultation process, the CRNS is seeking feedback on the guideline from registrants and external partners, including the public.
This review is being conducted through an online survey that will allow you to provide feedback on individual sections of the guideline document. A draft copy of the updated guideline is available to review while completing the survey.
- Review the updated draft Medication Management Guideline
- Access the survey here
The deadline to provide feedback is August 6, 2026, at 4:00 pm. Your responses will be anonymous and confidential.
Questions or comments are welcome and can be directed to Catharine Wirth at cwirth@crns.ca.
External Consultation: Artificial Intelligence (AI) in Nursing Practice Resource
The College of Registered Nurses of Saskatchewan (CRNS), the College of Licensed Practical Nurses of Saskatchewan (CLPNS) and the College of Registered Psychiatric Nurses of Saskatchewan (CRPNS) invite you to provide feedback on the jointly developed Artificial Intelligence in Nursing Practice resource.
This review is being conducted through an online survey that will allow you to review and provide feedback on individual sections of the document. A draft copy of the resource is available to review while completing the survey.
Access the online survey here.
View the draft copy of Artificial Intelligence in Nursing Practice
The deadline to provide feedback is July 23, 2026, at 4:00 pm. Your responses will be anonymous and confidential.
If you have any questions, please email Carole Reece, RN, at creece@crns.ca, Sabrina Warner, LPN, at swarner@clpns.com, or Rebecca Olney, RPN, at rolney@crpns.ca.
Thank you in advance for taking the time to provide feedback.
Share Your Feedback on EI Caregiving Benefits
The Department of Employment and Social Development Canada (ESDC) is conducting an evaluation of the Employment Insurance (EI) Family Caregiver Benefits and the Compassionate Care Benefits programs.
Nurse Practitioners are invited to participate in a survey to provide feedback on the requirement for a medical doctor or NP to complete a medical certificate for patients who are critically ill, injured or in need of end-of-life care.
Access the survey to share your feedback.
The survey takes approximately 10-15 minutes to complete and will remain open until October 2026.
Subscribe to the Drug Programs Newsletter
Nurse Practitioners are invited to subscribe to unScripted, a newsletter jointly produced by the Prescription Review Program and Opioid Agonist Therapy Program.
The newsletter provides prescribers with updates to drug programs, practice guidance and case discussions on complex prescribing scenarios.
The June 2026 issue of unScripted is now available.
To subscribe, email prp@cps.sk.ca. Past issues are available on the CPSS website.
Updated Resource: Professional Boundaries and the Nurse-Client Relationship
The updated Professional Boundaries and the Nurse-Client Relationship resource is now available on the CRNS website.
This resource has been updated on the CRNS five-year review cycle to:
- reference the CRNS’s Code of Conduct;
- further define key components, principles and concepts related to professional boundaries and the therapeutic nurse-client relationship;
- include warning signs of crossing a boundary, providing nursing care to family members or friends, commencing relationships with a current or former client, gifts, technology usage; and,
- include an updated decision-making framework for appropriate professional behaviour.
If you have questions, please contact a CRNS Practice and Education Nursing Advisor by email at practiceadvice@crns.ca or by phone at 1.800.667.9945.